A study of FoxA1 expression in thyroid tumors.

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• FoxA1 (Forkhead box A1) plays roles in embryonic development and is implicated in thyroid C-cell and anaplastic thyroid carcinoma biology.
• Its expression in various nonneoplastic and neoplastic thyroid lesions remains incompletely understood.

Purpose of the Study:

• To investigate FoxA1 expression across a spectrum of thyroid lesions and tumors.
• To evaluate FoxA1 as a diagnostic marker for medullary thyroid carcinoma.

Main Methods:

• Monoclonal anti-FoxA1 antibody staining was performed on a variety of thyroid tumors, lesions, and their mimics.
• FoxA1 expression patterns were compared with conventional markers in medullary thyroid carcinomas.

Main Results:

• All medullary thyroid carcinomas (100%) exhibited diffuse, strong, and homogeneous nuclear FoxA1 expression.
• FoxA1 was negative in follicular neoplasms, papillary thyroid carcinomas, and poorly differentiated carcinomas.
• FoxA1 showed expression in 55% of anaplastic thyroid carcinomas, C-cell hyperplasia, and solid cell nests, but not in nodular hyperplasia, Hashimoto thyroiditis, Graves disease, paragangliomas, or parathyroid lesions.

Conclusions:

• FoxA1 is a highly sensitive and specific marker for medullary thyroid carcinoma, outperforming calcitonin and CEA.
• Its uniform staining quality makes FoxA1 a valuable ancillary diagnostic tool for medullary thyroid carcinoma.